nodes	percent_of_prediction	percent_of_DWPC	metapath
Eprosartan—hypertension—chronic kidney failure	0.59	1	CtDrD
Eprosartan—ABCC2—chronic kidney failure	0.335	1	CbGaD
Eprosartan—CYP2C9—cardial valve—chronic kidney failure	0.00808	0.274	CbGeAlD
Eprosartan—AGTR1—nephron—chronic kidney failure	0.00451	0.153	CbGeAlD
Eprosartan—AGTR1—artery—chronic kidney failure	0.00252	0.0855	CbGeAlD
Eprosartan—AGTR1—blood plasma—chronic kidney failure	0.00189	0.0641	CbGeAlD
Eprosartan—CYP2C9—urine—chronic kidney failure	0.00174	0.0592	CbGeAlD
Eprosartan—AGTR1—nephron tubule—chronic kidney failure	0.000974	0.0331	CbGeAlD
Eprosartan—CYP2C9—blood plasma—chronic kidney failure	0.00091	0.0309	CbGeAlD
Eprosartan—AGTR1—renal system—chronic kidney failure	0.000886	0.0301	CbGeAlD
Eprosartan—AGTR1—cardiovascular system—chronic kidney failure	0.000875	0.0297	CbGeAlD
Eprosartan—AGTR1—kidney—chronic kidney failure	0.000856	0.0291	CbGeAlD
Eprosartan—AGTR1—cortex of kidney—chronic kidney failure	0.000834	0.0283	CbGeAlD
Eprosartan—ABCC2—nephron tubule—chronic kidney failure	0.000704	0.0239	CbGeAlD
Eprosartan—AGTR1—blood—chronic kidney failure	0.000692	0.0235	CbGeAlD
Eprosartan—Losartan—ACE—chronic kidney failure	0.000687	0.332	CrCbGaD
Eprosartan—ABCC2—renal system—chronic kidney failure	0.00064	0.0217	CbGeAlD
Eprosartan—ABCC2—kidney—chronic kidney failure	0.000619	0.021	CbGeAlD
Eprosartan—ABCC2—cortex of kidney—chronic kidney failure	0.000603	0.0205	CbGeAlD
Eprosartan—ABCC2—digestive system—chronic kidney failure	0.000525	0.0178	CbGeAlD
Eprosartan—Losartan—CYP2C19—chronic kidney failure	0.000507	0.245	CrCbGaD
Eprosartan—ABCC2—blood—chronic kidney failure	0.0005	0.017	CbGeAlD
Eprosartan—CYP2C9—cardiovascular system—chronic kidney failure	0.000421	0.0143	CbGeAlD
Eprosartan—CYP2C9—digestive system—chronic kidney failure	0.00035	0.0119	CbGeAlD
Eprosartan—CYP2C9—blood—chronic kidney failure	0.000333	0.0113	CbGeAlD
Eprosartan—Losartan—CYP3A4—chronic kidney failure	0.000323	0.156	CrCbGaD
Eprosartan—Losartan—ALB—chronic kidney failure	0.000281	0.136	CrCbGaD
Eprosartan—Losartan—ABCB1—chronic kidney failure	0.000269	0.13	CrCbGaD
Eprosartan—CYP2C9—Constitutive Androstane Receptor Pathway—CYP2C19—chronic kidney failure	0.000225	0.00522	CbGpPWpGaD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—NOS3—chronic kidney failure	0.00022	0.00511	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—KEAP1—chronic kidney failure	0.000211	0.00491	CbGpPWpGaD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—RELA—chronic kidney failure	0.000207	0.00481	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—NPY—chronic kidney failure	0.000197	0.00458	CbGpPWpGaD
Eprosartan—CYP2C9—Xenobiotics—CYP1A1—chronic kidney failure	0.000193	0.00448	CbGpPWpGaD
Eprosartan—AGTR1—G alpha (q) signalling events—OXT—chronic kidney failure	0.000193	0.00448	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—ABCC3—chronic kidney failure	0.000191	0.00444	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—OXT—chronic kidney failure	0.00019	0.00442	CbGpPWpGaD
Eprosartan—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2B6—chronic kidney failure	0.000189	0.0044	CbGpPWpGaD
Eprosartan—CYP2C9—Oxidation by Cytochrome P450—CYP2B6—chronic kidney failure	0.000187	0.00434	CbGpPWpGaD
Eprosartan—CYP2C9—Tamoxifen metabolism—CYP1A1—chronic kidney failure	0.000185	0.00431	CbGpPWpGaD
Eprosartan—AGTR1—G alpha (q) signalling events—NPS—chronic kidney failure	0.000182	0.00424	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—NPS—chronic kidney failure	0.00018	0.00419	CbGpPWpGaD
Eprosartan—CYP2C9—Constitutive Androstane Receptor Pathway—CYP3A4—chronic kidney failure	0.000178	0.00413	CbGpPWpGaD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—NFKB1—chronic kidney failure	0.000174	0.00405	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—chronic kidney failure	0.000172	0.004	CbGpPWpGaD
Eprosartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—chronic kidney failure	0.000169	0.00394	CbGpPWpGaD
Eprosartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—chronic kidney failure	0.000166	0.00387	CbGpPWpGaD
Eprosartan—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2C18—chronic kidney failure	0.000164	0.00381	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—chronic kidney failure	0.000163	0.0038	CbGpPWpGaD
Eprosartan—CYP2C9—Oxidation by Cytochrome P450—CYP2C18—chronic kidney failure	0.000162	0.00376	CbGpPWpGaD
Eprosartan—CYP2C9—Arachidonic acid metabolism—CYP2C19—chronic kidney failure	0.000157	0.00365	CbGpPWpGaD
Eprosartan—CYP2C9—Phase 1 - Functionalization of compounds—CYP2B6—chronic kidney failure	0.000153	0.00356	CbGpPWpGaD
Eprosartan—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—chronic kidney failure	0.000144	0.00334	CbGpPWpGaD
Eprosartan—CYP2C9—Arachidonic acid metabolism—PTGS1—chronic kidney failure	0.000144	0.00334	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—DRD1—chronic kidney failure	0.000138	0.00322	CbGpPWpGaD
Eprosartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—chronic kidney failure	0.000137	0.00319	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HBEGF—chronic kidney failure	0.000136	0.00316	CbGpPWpGaD
Eprosartan—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2C19—chronic kidney failure	0.000136	0.00316	CbGpPWpGaD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—chronic kidney failure	0.000136	0.00315	CbGpPWpGaD
Eprosartan—CYP2C9—Oxidation by Cytochrome P450—CYP2C19—chronic kidney failure	0.000134	0.00312	CbGpPWpGaD
Eprosartan—CYP2C9—Phase 1 - Functionalization of compounds—CYP2C18—chronic kidney failure	0.000133	0.00309	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—NPY—chronic kidney failure	0.000132	0.00307	CbGpPWpGaD
Eprosartan—AGTR1—G alpha (q) signalling events—AVP—chronic kidney failure	0.000132	0.00307	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—AVP—chronic kidney failure	0.00013	0.00303	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—IL1B—chronic kidney failure	0.00013	0.00301	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—OXT—chronic kidney failure	0.000127	0.00296	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CRHR1—chronic kidney failure	0.000127	0.00295	CbGpPWpGaD
Eprosartan—AGTR1—G alpha (q) signalling events—EDN1—chronic kidney failure	0.000125	0.00292	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—EDN1—chronic kidney failure	0.000124	0.00288	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CCL5—chronic kidney failure	0.000123	0.00286	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—NPS—chronic kidney failure	0.000121	0.00281	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—DRD1—chronic kidney failure	0.000119	0.00276	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—chronic kidney failure	0.000118	0.00274	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—PTH—chronic kidney failure	0.000116	0.00269	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—HBEGF—chronic kidney failure	0.000116	0.00269	CbGpPWpGaD
Eprosartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—chronic kidney failure	0.000115	0.00268	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic kidney failure	0.000112	0.00261	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CCR5—chronic kidney failure	0.000111	0.00258	CbGpPWpGaD
Eprosartan—CYP2C9—Phase 1 - Functionalization of compounds—CYP2C19—chronic kidney failure	0.00011	0.00256	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—VEGFA—chronic kidney failure	0.00011	0.00255	CbGpPWpGaD
Eprosartan—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP3A4—chronic kidney failure	0.000107	0.0025	CbGpPWpGaD
Eprosartan—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—chronic kidney failure	0.000106	0.00247	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC34A1—chronic kidney failure	0.000102	0.00238	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—TGFB1—chronic kidney failure	0.000101	0.00234	CbGpPWpGaD
Eprosartan—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—chronic kidney failure	0.000101	0.00234	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—NPY—chronic kidney failure	0.000101	0.00234	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CRH—chronic kidney failure	9.71e-05	0.00226	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—OXT—chronic kidney failure	9.71e-05	0.00226	CbGpPWpGaD
Eprosartan—AGTR1—G alpha (q) signalling events—F2—chronic kidney failure	9.63e-05	0.00224	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—F2—chronic kidney failure	9.5e-05	0.00221	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—TNF—chronic kidney failure	9.41e-05	0.00219	CbGpPWpGaD
Eprosartan—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic kidney failure	9.26e-05	0.00215	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—NPS—chronic kidney failure	9.2e-05	0.00214	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—DRD1—chronic kidney failure	9.03e-05	0.0021	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—AVP—chronic kidney failure	8.74e-05	0.00203	CbGpPWpGaD
Eprosartan—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—chronic kidney failure	8.71e-05	0.00203	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC22A2—chronic kidney failure	8.69e-05	0.00202	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR5—chronic kidney failure	8.67e-05	0.00202	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—POMC—chronic kidney failure	8.66e-05	0.00201	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—chronic kidney failure	8.61e-05	0.002	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CCL2—chronic kidney failure	8.47e-05	0.00197	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC7A9—chronic kidney failure	8.47e-05	0.00197	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic kidney failure	8.31e-05	0.00193	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL5—chronic kidney failure	8.25e-05	0.00192	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—CYP2B6—chronic kidney failure	8.14e-05	0.00189	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—ABCG1—chronic kidney failure	8.08e-05	0.00188	CbGpPWpGaD
Eprosartan—CYP2C9—Metapathway biotransformation—CYP2B6—chronic kidney failure	8.03e-05	0.00187	CbGpPWpGaD
Eprosartan—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic kidney failure	8.01e-05	0.00186	CbGpPWpGaD
Eprosartan—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic kidney failure	7.9e-05	0.00184	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC6A13—chronic kidney failure	7.45e-05	0.00173	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR5—chronic kidney failure	7.43e-05	0.00173	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CRHR1—chronic kidney failure	7.16e-05	0.00166	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—CYP2C18—chronic kidney failure	7.06e-05	0.00164	CbGpPWpGaD
Eprosartan—CYP2C9—Metapathway biotransformation—CYP2C18—chronic kidney failure	6.96e-05	0.00162	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—AVP—chronic kidney failure	6.65e-05	0.00155	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—PTH—chronic kidney failure	6.55e-05	0.00152	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CRHR1—chronic kidney failure	6.5e-05	0.00151	CbGpPWpGaD
Eprosartan—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic kidney failure	6.49e-05	0.00151	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—F2—chronic kidney failure	6.37e-05	0.00148	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—EDN1—chronic kidney failure	6.33e-05	0.00147	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CCL5—chronic kidney failure	6.28e-05	0.00146	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—ABCC3—chronic kidney failure	6.12e-05	0.00142	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—GCKR—chronic kidney failure	6.12e-05	0.00142	CbGpPWpGaD
Eprosartan—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—chronic kidney failure	5.97e-05	0.00139	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PTH—chronic kidney failure	5.95e-05	0.00138	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—CYP2C19—chronic kidney failure	5.85e-05	0.00136	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—POMC—chronic kidney failure	5.81e-05	0.00135	CbGpPWpGaD
Eprosartan—CYP2C9—Metapathway biotransformation—CYP2C19—chronic kidney failure	5.77e-05	0.00134	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—NPY—chronic kidney failure	5.69e-05	0.00132	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL2—chronic kidney failure	5.68e-05	0.00132	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CCR5—chronic kidney failure	5.66e-05	0.00132	CbGpPWpGaD
Eprosartan—CYP2C9—Arachidonic acid metabolism—PTGS2—chronic kidney failure	5.51e-05	0.00128	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—OXT—chronic kidney failure	5.49e-05	0.00128	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CRH—chronic kidney failure	5.49e-05	0.00128	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—COL4A5—chronic kidney failure	5.45e-05	0.00127	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—FABP1—chronic kidney failure	5.44e-05	0.00127	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—PTGS1—chronic kidney failure	5.35e-05	0.00124	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—NPS—chronic kidney failure	5.2e-05	0.00121	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—NPY—chronic kidney failure	5.16e-05	0.0012	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—DRD1—chronic kidney failure	5.1e-05	0.00119	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TFDP2—chronic kidney failure	5.07e-05	0.00118	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CRH—chronic kidney failure	4.98e-05	0.00116	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—OXT—chronic kidney failure	4.98e-05	0.00116	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PIP5K1B—chronic kidney failure	4.96e-05	0.00115	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—F2—chronic kidney failure	4.85e-05	0.00113	CbGpPWpGaD
Eprosartan—CYP2C9—Phase 1 - Functionalization of compounds—POMC—chronic kidney failure	4.84e-05	0.00113	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—NPS—chronic kidney failure	4.72e-05	0.0011	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—ACAT1—chronic kidney failure	4.72e-05	0.0011	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—DRD1—chronic kidney failure	4.63e-05	0.00108	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—CYP3A4—chronic kidney failure	4.63e-05	0.00108	CbGpPWpGaD
Eprosartan—CYP2C9—Metapathway biotransformation—CYP3A4—chronic kidney failure	4.56e-05	0.00106	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PGF—chronic kidney failure	4.52e-05	0.00105	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—POMC—chronic kidney failure	4.42e-05	0.00103	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CCL2—chronic kidney failure	4.33e-05	0.00101	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PRKAG2—chronic kidney failure	4.25e-05	0.000987	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—chronic kidney failure	4.19e-05	0.000974	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—COL4A3—chronic kidney failure	4.03e-05	0.000936	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—HBEGF—chronic kidney failure	3.94e-05	0.000916	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—TGFB1—chronic kidney failure	3.85e-05	0.000895	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CRHR1—chronic kidney failure	3.84e-05	0.000893	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—AVP—chronic kidney failure	3.76e-05	0.000874	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—ABCG1—chronic kidney failure	3.73e-05	0.000867	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—LRP2—chronic kidney failure	3.68e-05	0.000856	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PIP5K1B—chronic kidney failure	3.65e-05	0.000849	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—EDN1—chronic kidney failure	3.58e-05	0.000832	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CCL5—chronic kidney failure	3.55e-05	0.000825	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PTH—chronic kidney failure	3.51e-05	0.000817	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—LCAT—chronic kidney failure	3.51e-05	0.000816	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—CYP1A1—chronic kidney failure	3.45e-05	0.000802	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CYBB—chronic kidney failure	3.42e-05	0.000796	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—AVP—chronic kidney failure	3.41e-05	0.000794	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic kidney failure	3.41e-05	0.000792	CbGpPWpGaD
Eprosartan—CYP2C9—Metapathway biotransformation—CYP1A1—chronic kidney failure	3.4e-05	0.000791	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—EDN1—chronic kidney failure	3.25e-05	0.000755	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—FGF23—chronic kidney failure	3.24e-05	0.000754	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CCL5—chronic kidney failure	3.22e-05	0.000749	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—AVP—chronic kidney failure	3.22e-05	0.000748	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CCR5—chronic kidney failure	3.2e-05	0.000743	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PRKD1—chronic kidney failure	3.13e-05	0.000727	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PRKAG2—chronic kidney failure	3.13e-05	0.000727	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—ABCB1—chronic kidney failure	3.11e-05	0.000724	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NPY—chronic kidney failure	3.05e-05	0.000709	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CRH—chronic kidney failure	2.94e-05	0.000684	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—OXT—chronic kidney failure	2.94e-05	0.000684	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—SREBF2—chronic kidney failure	2.93e-05	0.000681	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CCR5—chronic kidney failure	2.9e-05	0.000675	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—ABCC3—chronic kidney failure	2.83e-05	0.000657	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NCF1—chronic kidney failure	2.82e-05	0.000655	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NPS—chronic kidney failure	2.79e-05	0.000649	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—LPIN1—chronic kidney failure	2.77e-05	0.000643	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—F2—chronic kidney failure	2.74e-05	0.000638	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—DRD1—chronic kidney failure	2.74e-05	0.000636	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—LRP2—chronic kidney failure	2.71e-05	0.00063	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CYBA—chronic kidney failure	2.65e-05	0.000616	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—PPARA—chronic kidney failure	2.62e-05	0.000609	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—POMC—chronic kidney failure	2.57e-05	0.000598	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—POMC—chronic kidney failure	2.5e-05	0.000581	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—F2—chronic kidney failure	2.49e-05	0.000579	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—FABP1—chronic kidney failure	2.42e-05	0.000564	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HBEGF—chronic kidney failure	2.33e-05	0.000541	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—CPT1A—chronic kidney failure	2.3e-05	0.000536	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GATM—chronic kidney failure	2.3e-05	0.000534	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—AGXT—chronic kidney failure	2.3e-05	0.000534	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—POMC—chronic kidney failure	2.27e-05	0.000528	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—chronic kidney failure	2.25e-05	0.000522	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—chronic kidney failure	2.25e-05	0.000522	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CCL2—chronic kidney failure	2.22e-05	0.000516	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ACAT1—chronic kidney failure	2.1e-05	0.000489	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—chronic kidney failure	2.08e-05	0.000483	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—chronic kidney failure	2.05e-05	0.000478	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—AVP—chronic kidney failure	2.02e-05	0.000469	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—SREBF1—chronic kidney failure	2.01e-05	0.000468	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—chronic kidney failure	1.96e-05	0.000456	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—MLXIPL—chronic kidney failure	1.95e-05	0.000454	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—ALB—chronic kidney failure	1.95e-05	0.000453	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—EDN1—chronic kidney failure	1.92e-05	0.000446	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—FASN—chronic kidney failure	1.92e-05	0.000446	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCL5—chronic kidney failure	1.9e-05	0.000443	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—LPL—chronic kidney failure	1.86e-05	0.000433	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SLC22A2—chronic kidney failure	1.79e-05	0.000416	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NGF—chronic kidney failure	1.76e-05	0.00041	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—chronic kidney failure	1.75e-05	0.000406	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCR5—chronic kidney failure	1.72e-05	0.000399	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ABCG1—chronic kidney failure	1.66e-05	0.000386	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PIP5K1B—chronic kidney failure	1.63e-05	0.000378	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ARG2—chronic kidney failure	1.59e-05	0.00037	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—LCAT—chronic kidney failure	1.56e-05	0.000363	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—F2—chronic kidney failure	1.47e-05	0.000342	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—DDC—chronic kidney failure	1.43e-05	0.000333	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CYP2B6—chronic kidney failure	1.39e-05	0.000324	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PRKD1—chronic kidney failure	1.39e-05	0.000324	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PRKAG2—chronic kidney failure	1.39e-05	0.000324	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IRS1—chronic kidney failure	1.39e-05	0.000324	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—LPL—chronic kidney failure	1.37e-05	0.000319	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—POMC—chronic kidney failure	1.34e-05	0.000312	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic kidney failure	1.32e-05	0.000308	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCL2—chronic kidney failure	1.31e-05	0.000305	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SREBF2—chronic kidney failure	1.3e-05	0.000303	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IGF1—chronic kidney failure	1.29e-05	0.0003	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ABCC3—chronic kidney failure	1.26e-05	0.000293	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GCKR—chronic kidney failure	1.26e-05	0.000293	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—LPIN1—chronic kidney failure	1.23e-05	0.000286	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—SERPINE1—chronic kidney failure	1.22e-05	0.000285	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—KRAS—chronic kidney failure	1.21e-05	0.000282	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—chronic kidney failure	1.21e-05	0.000282	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CYP2C18—chronic kidney failure	1.21e-05	0.000281	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—LRP2—chronic kidney failure	1.21e-05	0.000281	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NOS3—chronic kidney failure	1.17e-05	0.000272	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—RELA—chronic kidney failure	1.1e-05	0.000256	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CPT1A—chronic kidney failure	1.03e-05	0.000239	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—LIPC—chronic kidney failure	1e-05	0.000233	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CYP2C19—chronic kidney failure	1e-05	0.000233	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—chronic kidney failure	9.87e-06	0.000229	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—IL6—chronic kidney failure	9.86e-06	0.000229	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NFKB1—chronic kidney failure	9.28e-06	0.000216	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SCARB1—chronic kidney failure	9.24e-06	0.000215	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PTGS1—chronic kidney failure	9.15e-06	0.000213	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic kidney failure	9e-06	0.000209	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SREBF1—chronic kidney failure	8.97e-06	0.000209	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—HMGCR—chronic kidney failure	8.73e-06	0.000203	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—FASN—chronic kidney failure	8.54e-06	0.000199	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—VEGFA—chronic kidney failure	8.42e-06	0.000196	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CYP3A4—chronic kidney failure	7.91e-06	0.000184	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	7.87e-06	0.000183	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ABCA1—chronic kidney failure	7.78e-06	0.000181	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TGFB1—chronic kidney failure	7.73e-06	0.00018	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—KRAS—chronic kidney failure	7.16e-06	0.000166	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CAT—chronic kidney failure	6.59e-06	0.000153	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ABCB1—chronic kidney failure	6.41e-06	0.000149	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—LPL—chronic kidney failure	6.1e-06	0.000142	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CYP1A1—chronic kidney failure	5.9e-06	0.000137	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IL6—chronic kidney failure	5.83e-06	0.000135	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—MTHFR—chronic kidney failure	5.5e-06	0.000128	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PPARA—chronic kidney failure	5.39e-06	0.000125	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—POMC—chronic kidney failure	4.4e-06	0.000102	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ALB—chronic kidney failure	4.01e-06	9.32e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—NOS3—chronic kidney failure	3.83e-06	8.91e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PTGS2—chronic kidney failure	3.51e-06	8.15e-05	CbGpPWpGaD
